Fibrosis in Hypertrophic Cardiomyopathy Patients With and Without Sarcomere Gene Mutations

Abstract

Genotyped HCM patients with an identified sarcomere mutation have greater LGE and greater regional, but not global, ECV than HCM patients without an identified mutation. This difference in fibrosis may contribute to worse outcomes in patients with an identified HCM mutation.